Pharmacoepidemiology and Drug Safety
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q2 | 61.2% | 1.041 | Q1 | 85.0% |
| 2024 | 2.4 | Q2 | 62.9% | 1.022 | Q1 | 84.8% |
| 2023 | 2.4 | Q2 | 59.3% | 1.106 | Q1 | 87.8% |
| 2022 | 2.6 | Q3 | 51.1% | 1.067 | Q1 | 87.7% |
| 2021 | 2.7 | Q3 | 58.9% | 0.868 | Q2 | 83.3% |
| 2020 | — | — | 1.023 | Q2 | 85.8% | |
| 2019 | — | — | 1.223 | Q1 | 89.6% | |
| 2018 | — | — | 1.519 | Q1 | 92.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1053-8569
ISSN
1099-1557
country
GBcoverage
1992-2026